FOXI1 (Forkhead box protein I1) variants and mutations
FOXI1 (also known as Forkhead box protein I1) is a human protein-coding gene encoding a forkhead box protein I1 protein. It regulates genes needed for acid-base transport in kidney intercalated cells and ion homeostasis in the inner ear. Biallelic pathogenic variants can cause enlarged vestibular aqueduct with hearing loss, and disruption can also affect renal acidification. This analysis covers 933 FOXI1 variants and mutations. Of these, 83% have computational variant effect predictions. Disease context includes autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome, and hearing loss disorder. Example FOXI1 variants include S2R, S2G, and S2I.
Variant analysis overview
- Gene: FOXI1
- Protein: Forkhead box protein I1
- UniProt accession: Q12951
- Organism: Homo sapiens
- Variants analyzed: 933
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 539 unspecified-consequence records; 198 missense variants; 166 synonymous variants; 11 frameshift variants; 11 stop-gained variants; 4 in-frame deletions; 2 splice-region variants; 2 substitution
- Prediction scores: 773 variants have prediction scores (83% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome, hearing loss disorder, Enlarged vestibular aqueduct, autosomal recessive distal renal tubular acidosis, Sensorineural hearing impairment, Hearing impairment, deafness, renal tubular acidosis, breast carcinoma, self-injurious ideation, Usher syndrome.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable FOXI1 variants
Examples include S2R, S2G, S2I, S2S, S3F, S3P, S3S, F4L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2R (p.Ser2Arg), NCI-TCGA TCGA novel, TOPMed rs1758463774, REVEL 0.55, CADD 23.20, Variant assessed as somatic; moderate impact.
- S2G (p.Ser2Gly), gnomAD 5-170105961-A-G, REVEL 0.48, CADD 23.60
- S2I (p.Ser2Ile), gnomAD 5-170105962-G-T, REVEL 0.51, CADD 25.50
- S2S (p.Ser2Ser), gnomAD 5-170105963-C-T, CADD 9.66
- S3F (p.Ser3Phe), rs374176565, ClinGen CA3554927, ClinVar RCV004392270, ClinVar RCV005038653, REVEL 0.31, CADD 22.90, Uncertain significance, Autosomal recessive nonsyndromic hearing loss 4; not specified
- S3P (p.Ser3Pro), gnomAD 5-170105964-T-C, REVEL 0.39, CADD 22.20
- S3S (p.Ser3Ser), rs750881040, gnomAD 5-170105966-C-A, CADD 9.19
- F4L (p.Phe4Leu), NCI-TCGA Cosmic COSV6038, REVEL 0.51, CADD 22.60, Variant assessed as somatic; moderate impact.
- F4Y (p.Phe4Tyr), rs2532546282, ClinGen CA362123538, ClinVar RCV003014202, NCI-TCGA TCGA novel, Uncertain significance, not provided
- F4S (p.Phe4Ser), gnomAD 5-170105968-T-C, REVEL 0.42, CADD 23.20
- F4F (p.Phe4Phe), rs757881412, gnomAD 5-170105969-C-T, CADD 10.30
- D5A (p.Asp5Ala), Ensembl rs1581592021
- D5N (p.Asp5Asn), rs779571186, NCI-TCGA Cosmic COSV6038, cosmic curated COSV60388, ExAC rs779571186, REVEL 0.41, CADD 22.80, Uncertain significance
- D5Y (p.Asp5Tyr), ExAC rs779571186, TOPMed rs779571186, gnomAD rs779571186, REVEL 0.56, CADD 25.70, Uncertain significance, not specified
- D5D (p.Asp5Asp), rs146919679, gnomAD 5-170105972-C-T, CADD 9.88
- L6M (p.Leu6Met), NCI-TCGA Cosmic COSV6038, cosmic curated COSV60388, REVEL 0.28, CADD 22.50, Variant assessed as somatic; moderate impact.
- L6P (p.Leu6Pro), ExAC rs754631646, gnomAD rs754631646, REVEL 0.24, CADD 22.00
- L6V (p.Leu6Val), gnomAD 5-170105973-C-G, REVEL 0.27, CADD 16.70
- L6R (p.Leu6Arg), gnomAD 5-170105974-T-G, REVEL 0.30, CADD 22.40
- L6L (p.Leu6Leu), rs1758464341, gnomAD 5-170105975-G-A, CADD 8.16
- P7L (p.Pro7Leu), TOPMed rs1392589212, REVEL 0.22, CADD 15.70
- P7S (p.Pro7Ser), rs1307118466, NCI-TCGA Cosmic COSV6038, cosmic curated COSV60388, TOPMed rs1307118466, REVEL 0.21, CADD 16.50, Uncertain significance
- P7T (p.Pro7Thr), TOPMed rs1307118466, gnomAD rs1307118466, REVEL 0.20, CADD 17.30, Uncertain significance, Autosomal recessive nonsyndromic hearing loss 4
- P7Q (p.Pro7Gln), gnomAD 5-170105977-C-A, REVEL 0.20, CADD 10.00
- P7P (p.Pro7Pro), rs1190421315, gnomAD 5-170105978-G-A, CADD 3.58
- A8E (p.Ala8Glu), TOPMed rs1330324248, gnomAD rs1330324248, REVEL 0.26, CADD 14.10
- A8T (p.Ala8Thr), gnomAD rs1371952367, REVEL 0.21, CADD 13.40
- A8V (p.Ala8Val), TOPMed rs1330324248, gnomAD rs1330324248, REVEL 0.26, CADD 14.50
- A8A (p.Ala8Ala), rs781201414, gnomAD 5-170105981-G-C, CADD 0.62
- P9H (p.Pro9His), cosmic curated COSV99079, ExAC rs747944383, gnomAD rs747944383, REVEL 0.20, CADD 18.00
- P9S (p.Pro9Ser), gnomAD 5-170105982-C-T, REVEL 0.19, CADD 13.80
- P9P (p.Pro9Pro), rs769657776, gnomAD 5-170105984-C-G, CADD 8.58
- S10F (p.Ser10Phe), TOPMed rs1758465231, gnomAD rs1758465231, REVEL 0.51, CADD 24.00
- S10T (p.Ser10Thr), gnomAD 5-170105985-T-A, REVEL 0.33, CADD 22.60
- S10Y (p.Ser10Tyr), gnomAD 5-170105986-C-A, REVEL 0.52, CADD 23.70
- S10S (p.Ser10Ser), gnomAD 5-170105987-C-A, CADD 3.78
- P11Q (p.Pro11Gln), Ensembl rs1477667327, REVEL 0.28, CADD 19.60
- P11H (p.Pro11His), gnomAD 5-170105985-TC-T, CADD 23.90
- P11T (p.Pro11Thr), gnomAD 5-170105988-C-A, REVEL 0.23, CADD 17.30
- P12L (p.Pro12Leu), 1000Genomes rs749208705, ExAC rs749208705, gnomAD rs749208705, REVEL 0.33, CADD 22.60, Uncertain significance, Autosomal recessive nonsyndromic hearing loss 4
- P12P (p.Pro12Pro), rs772064917, gnomAD 5-170105993-T-A, CADD 0.93
- R13C (p.Arg13Cys), Ensembl rs267600548
- R13H (p.Arg13His), ExAC rs775617358, TOPMed rs775617358, gnomAD rs775617358, REVEL 0.38, CADD 22.60
- R13L (p.Arg13Leu), ExAC rs775617358, TOPMed rs775617358, gnomAD rs775617358, REVEL 0.39, CADD 22.20
- R13S (p.Arg13Ser), gnomAD 5-170105994-C-A, REVEL 0.25, CADD 19.00
- C14Y (p.Cys14Tyr), gnomAD 5-170105998-G-A, REVEL 0.55, CADD 26.00
- C14* (p.Cys14Ter), gnomAD 5-170105999-C-A, CADD 36.00
- C14C (p.Cys14Cys), rs2113894451, gnomAD 5-170105999-C-T, CADD 10.90
- S15N (p.Ser15Asn), NCI-TCGA Cosmic COSV6038, cosmic curated COSV60388, REVEL 0.41, CADD 23.20, Variant assessed as somatic; moderate impact.
- S15R (p.Ser15Arg), gnomAD rs1293560738, REVEL 0.48, CADD 22.20, Uncertain significance, not specified
- S15S (p.Ser15Ser), gnomAD 5-170106002-C-T, CADD 7.65
- P16L (p.Pro16Leu), gnomAD rs1467607385, REVEL 0.58, CADD 23.40
- P16R (p.Pro16Arg), gnomAD 5-170106004-C-G, REVEL 0.58, MetaLR 0.88
- Q17H (p.Gln17His), NCI-TCGA TCGA novel, gnomAD rs1325897462, REVEL 0.55, CADD 23.10, Variant assessed as somatic; moderate impact.
- Q17P (p.Gln17Pro), TOPMed rs1758466064, gnomAD rs1758466064
- Q17R (p.Gln17Arg), TOPMed rs1758466064, gnomAD rs1758466064, REVEL 0.62, CADD 25.80
- Q17S (p.Gln17Ser), gnomAD 5-170106001-GC-G, CADD 22.40
- Q17* (p.Gln17Ter), gnomAD 5-170106006-C-T, CADD 37.00
- Q17L (p.Gln17Leu), gnomAD 5-170106007-A-T, REVEL 0.61, MetaLR 0.86
- F18L (p.Phe18Leu), gnomAD rs1282727197, REVEL 0.48, CADD 23.80
- P19A (p.Pro19Ala), Ensembl rs1758466396, REVEL 0.61, CADD 24.30
- P19H (p.Pro19His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P19S (p.Pro19Ser), gnomAD 5-170106012-C-T, REVEL 0.59, MetaLR 0.87
- P19L (p.Pro19Leu), gnomAD 5-170106013-C-T, REVEL 0.65, MetaLR 0.88
- P19P (p.Pro19Pro), gnomAD 5-170106014-C-T, CADD 10.90
- S20R (p.Ser20Arg), Ensembl rs2113894475
- S20G (p.Ser20Gly), gnomAD 5-170106015-A-G, REVEL 0.34, MetaLR 0.74
- S20S (p.Ser20Ser), gnomAD 5-170106017-C-T, CADD 10.40
- I21F (p.Ile21Phe), TOPMed rs1421008071
- I21M (p.Ile21Met), ExAC rs768858662, TOPMed rs768858662, gnomAD rs768858662, Uncertain significance
- I21T (p.Ile21Thr), gnomAD 5-170106019-T-C, REVEL 0.28, MetaLR 0.62
- I21I (p.Ile21Ile), rs768858662, gnomAD 5-170106020-C-T, CADD 7.06
- G22S (p.Gly22Ser), ExAC rs777033522, gnomAD rs777033522, REVEL 0.54, CADD 25.30
- G22V (p.Gly22Val), gnomAD rs1287119122, REVEL 0.54, CADD 24.50
- Q23K (p.Gln23Lys), gnomAD 5-170106024-C-A, REVEL 0.53, MetaLR 0.88
- Q23Q (p.Gln23Gln), gnomAD 5-170106026-G-A, CADD 8.15
- E24A (p.Glu24Ala), Ensembl rs2113894491
- E24D (p.Glu24Asp), rs2532546480, ClinGen CA362123788, ClinVar RCV002597298, Uncertain significance, not provided
- E24Q (p.Glu24Gln), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10008, Variant assessed as somatic; moderate impact.
- P25L (p.Pro25Leu), cosmic curated COSV10883, Ensembl rs1758467063, REVEL 0.35, CADD 20.30
- P25S (p.Pro25Ser), ExAC rs762176954, TOPMed rs762176954, gnomAD rs762176954, REVEL 0.49, CADD 23.00
- P25T (p.Pro25Thr), ExAC rs762176954, TOPMed rs762176954, gnomAD rs762176954, REVEL 0.53, CADD 23.00
- P25A (p.Pro25Ala), gnomAD 5-170106030-C-G, REVEL 0.47, MetaLR 0.75
- P25H (p.Pro25His), gnomAD 5-170106031-C-A, REVEL 0.52, MetaLR 0.87
- P25P (p.Pro25Pro), gnomAD 5-170106032-C-T, CADD 8.71
- P26H (p.Pro26His), rs373020583, ClinGen CA3554947, ClinVar RCV003082048, ClinVar RCV004073102, REVEL 0.52, CADD 24.10, Uncertain significance, not provided; not specified
- P26L (p.Pro26Leu), ESP rs373020583, ExAC rs373020583, TOPMed rs373020583, gnomAD rs373020583, Uncertain significance
- P26R (p.Pro26Arg), rs373020583, ClinGen CA3554948, ClinVar RCV001929987, ESP rs373020583, REVEL 0.50, CADD 24.10, Uncertain significance, not provided
- P26T (p.Pro26Thr), ExAC rs750918345
- P26P (p.Pro26Pro), rs751079599, gnomAD 5-170106035-C-G, CADD 0.70
- E27A (p.Glu27Ala), rs752331785, ClinGen CA3554952, ClinVar RCV003144084, ClinVar RCV005099406, REVEL 0.61, CADD 25.50, Uncertain significance, not specified; not provided; Autosomal recessive nonsyndromic hearing loss 4
- E27K (p.Glu27Lys), rs781004930, NCI-TCGA Cosmic COSV6038, cosmic curated COSV60389, ExAC rs781004930, REVEL 0.63, CADD 26.30, Variant assessed as somatic; moderate impact.
- E27R (p.Glu27Arg), gnomAD 5-170106029-GC-G, CADD 25.60
- E27E (p.Glu27Glu), gnomAD 5-170106038-G-A, CADD 8.09
- M28I (p.Met28Ile), NCI-TCGA Cosmic COSV6038, cosmic curated COSV60388, Variant assessed as somatic; moderate impact.
- M28L (p.Met28Leu), gnomAD rs1159049162, REVEL 0.28, CADD 12.50
- M28T (p.Met28Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- M28V (p.Met28Val), gnomAD 5-170106039-A-G, REVEL 0.53, MetaLR 0.77
- N29S (p.Asn29Ser), ExAC rs756006075, TOPMed rs756006075, gnomAD rs756006075, REVEL 0.30, CADD 9.89
- N29N (p.Asn29Asn), gnomAD 5-170106044-C-T, CADD 5.23
- L30H (p.Leu30His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L30I (p.Leu30Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L30L (p.Leu30Leu), gnomAD 5-170106047-C-G, CADD 2.43
- Y31* (p.Tyr31Ter), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10008, Variant assessed as somatic; high impact.
- Y31C (p.Tyr31Cys), rs777573595, ClinGen CA3554954, ClinVar RCV001375208, ExAC rs777573595, REVEL 0.90, CADD 27.40, Likely pathogenic, Hearing impairment
- Y31Y (p.Tyr31Tyr), rs1288193095, gnomAD 5-170106050-C-T, CADD 7.79
- Y32C (p.Tyr32Cys), gnomAD rs1384425039, REVEL 0.28, CADD 22.40
- Y32* (p.Tyr32Ter), gnomAD 5-170106053-T-G, CADD 34.00
- E33D (p.Glu33Asp), NCI-TCGA Cosmic COSV6038, cosmic curated COSV60387, Variant assessed as somatic; moderate impact.
- E33K (p.Glu33Lys), gnomAD 5-170106054-G-A, REVEL 0.62, MetaLR 0.80
- N34D (p.Asn34Asp), ExAC rs749231593, REVEL 0.51, CADD 22.90
- N34S (p.Asn34Ser), TOPMed rs1758468546
- N34N (p.Asn34Asn), gnomAD 5-170106059-C-T, CADD 8.22
- N34K (p.Asn34Lys), gnomAD 5-170106059-C-G, REVEL 0.60, MetaLR 0.83
- F35L (p.Phe35Leu), Ensembl rs1581592161, REVEL 0.31, CADD 20.70
- F36del (p.Phe36del), gnomAD 5-170106058-ACTT-, CADD 18.10
- F36F (p.Phe36Phe), rs1387425041, gnomAD 5-170106065-C-T, CADD 10.80
- H37N (p.His37Asn), TOPMed rs1199043860, REVEL 0.40, CADD 19.00
- H37R (p.His37Arg), ESP rs375487385, ExAC rs375487385, TOPMed rs375487385, gnomAD rs375487385, REVEL 0.43, CADD 22.90
- H37Y (p.His37Tyr), gnomAD 5-170106066-C-T, REVEL 0.24, MetaLR 0.77
- H37H (p.His37His), rs970250660, gnomAD 5-170106068-C-T, CADD 5.91
- P38Q (p.Pro38Gln), ExAC rs780063212, gnomAD rs780063212, REVEL 0.29, CADD 16.90
- P38T (p.Pro38Thr), TOPMed rs1758468990, REVEL 0.49, CADD 20.60
- Q39H (p.Gln39His), gnomAD 5-170106074-G-T, REVEL 0.53, MetaLR 0.78
- G40S (p.Gly40Ser), cosmic curated COSV10738, ESP rs369758264, ExAC rs369758264, TOPMed rs369758264, REVEL 0.18, CADD 15.80
- G40C (p.Gly40Cys), gnomAD 5-170106075-G-T, REVEL 0.32, MetaLR 0.70
- G40G (p.Gly40Gly), rs535372917, gnomAD 5-170106077-C-A, CADD 2.06
- V41L (p.Val41Leu), ExAC rs768660570, TOPMed rs768660570, gnomAD rs768660570, REVEL 0.17, CADD 2.98, Uncertain significance
- V41M (p.Val41Met), ExAC rs768660570, TOPMed rs768660570, gnomAD rs768660570, REVEL 0.15, CADD 10.40, Uncertain significance, Autosomal recessive nonsyndromic hearing loss 4
- V41V (p.Val41Val), gnomAD 5-170106080-G-A, CADD 7.98
- P42R (p.Pro42Arg), gnomAD 5-170106082-C-G, REVEL 0.45, MetaLR 0.73
- S43G (p.Ser43Gly), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10008, Variant assessed as somatic; moderate impact.
- S43I (p.Ser43Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S43R (p.Ser43Arg), TOPMed rs1022683356, REVEL 0.52, CADD 22.80
- S43S (p.Ser43Ser), rs1022683356, gnomAD 5-170106086-C-T, CADD 8.62
- P44L (p.Pro44Leu), rs142009641, ClinGen CA3554960, cosmic curated COSV10609, ClinVar RCV000956919, REVEL 0.54, CADD 23.20, Likely benign, not provided
- P44S (p.Pro44Ser), Ensembl rs1758469664, REVEL 0.50, CADD 22.70
- P44P (p.Pro44Pro), gnomAD 5-170106089-T-C, CADD 7.31
- Q45H (p.Gln45His), NCI-TCGA TCGA novel, TOPMed rs941579883, gnomAD rs941579883, REVEL 0.46, CADD 23.60, Variant assessed as somatic; moderate impact.
- Q45P (p.Gln45Pro), gnomAD rs1214342699
- R46G (p.Arg46Gly), ExAC rs761978045, TOPMed rs761978045, gnomAD rs761978045, REVEL 0.60, CADD 23.00
- R46L (p.Arg46Leu), NCI-TCGA Cosmic COSV6039, Variant assessed as somatic; moderate impact.
- R46P (p.Arg46Pro), ExAC rs770196010, gnomAD rs770196010, REVEL 0.58, CADD 28.10
- R46W (p.Arg46Trp), NCI-TCGA Cosmic COSV6038, NCI-TCGA Cosmic COSV6039, cosmic curated COSV60390, REVEL 0.66, CADD 23.80, Variant assessed as somatic; moderate impact.
- R46R (p.Arg46Arg), rs761978045, gnomAD 5-170106093-C-A, CADD 7.72
- P47R (p.Pro47Arg), gnomAD 5-170106097-C-G, REVEL 0.67, MetaLR 0.90
- P47L (p.Pro47Leu), gnomAD 5-170106097-C-T, REVEL 0.66, MetaLR 0.90
- P47P (p.Pro47Pro), rs773599384, gnomAD 5-170106098-C-T, CADD 6.23
- S48F (p.Ser48Phe), rs1758470315, ClinGen CA362123977, NCI-TCGA Cosmic COSV1000, cosmic curated COSV10008, REVEL 0.42, CADD 24.30, Uncertain significance, not provided
- S48T (p.Ser48Thr), TOPMed rs1385371198
- S48S (p.Ser48Ser), gnomAD 5-170106101-C-G, CADD 9.20
- F49F (p.Phe49Phe), rs1228717621, gnomAD 5-170106104-C-T, CADD 7.65
- E50K (p.Glu50Lys), gnomAD 5-170106105-G-A, REVEL 0.30, MetaLR 0.64
- E50* (p.Glu50Ter), gnomAD 5-170106105-G-T, CADD 38.00
- E50G (p.Glu50Gly), gnomAD 5-170106106-A-G, REVEL 0.26, MetaLR 0.53
- E50D (p.Glu50Asp), gnomAD 5-170106107-G-C, REVEL 0.17, MetaLR 0.55
- G51E (p.Gly51Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G51R (p.Gly51Arg), 1000Genomes rs547608599, ExAC rs547608599, TOPMed rs547608599, gnomAD rs547608599, REVEL 0.26, CADD 22.80, Uncertain significance, Autosomal recessive nonsyndromic hearing loss 4
- G51W (p.Gly51Trp), gnomAD 5-170106108-G-T, REVEL 0.38, MetaLR 0.75
- G51V (p.Gly51Val), gnomAD 5-170106109-G-T, REVEL 0.15, MetaLR 0.68
- G51G (p.Gly51Gly), rs1758470730, gnomAD 5-170106110-G-A, CADD 2.87
- G52A (p.Gly52Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G52C (p.Gly52Cys), ExAC rs766896773, gnomAD rs766896773, REVEL 0.26, CADD 23.30
- G52D (p.Gly52Asp), gnomAD rs1467776517, REVEL 0.22, CADD 21.90
- G52S (p.Gly52Ser), gnomAD 5-170106111-G-A, REVEL 0.13, MetaLR 0.62
- G52G (p.Gly52Gly), gnomAD 5-170106113-C-A, CADD 4.06
- G53S (p.Gly53Ser), gnomAD 5-170106114-G-A, REVEL 0.39, MetaLR 0.82
- G53G (p.Gly53Gly), rs146116253, gnomAD 5-170106116-C-T, CADD 11.70
- E54D (p.Glu54Asp), ExAC rs767098191, TOPMed rs767098191, gnomAD rs767098191, REVEL 0.25, CADD 14.60
- E54G (p.Glu54Gly), rs1417785705, ClinGen CA362124012, ClinVar RCV001152644, TOPMed rs1417785705, REVEL 0.41, CADD 22.80, Uncertain significance, Autosomal recessive nonsyndromic hearing loss 4
- E54K (p.Glu54Lys), cosmic curated COSV60388, 1000Genomes rs561448899, ExAC rs561448899, gnomAD rs561448899, REVEL 0.43, CADD 24.40
- E54E (p.Glu54Glu), rs767098191, gnomAD 5-170106119-G-A, CADD 8.06
- Y55C (p.Tyr55Cys), TOPMed rs1178035608, gnomAD rs1178035608, REVEL 0.81, CADD 24.90
- Y55N (p.Tyr55Asn), Ensembl rs933979218, REVEL 0.81, CADD 25.50
- Y55H (p.Tyr55His), gnomAD 5-170106120-T-C, REVEL 0.71, MetaLR 0.87
- Y55Y (p.Tyr55Tyr), gnomAD 5-170106122-T-C, CADD 3.64
- G56A (p.Gly56Ala), TOPMed rs1445493418, gnomAD rs1445493418, REVEL 0.20, CADD 15.00
- G56E (p.Gly56Glu), TOPMed rs1445493418, gnomAD rs1445493418, REVEL 0.26, CADD 22.70
- G56V (p.Gly56Val), gnomAD 5-170106124-G-T, REVEL 0.27, MetaLR 0.73
- G56G (p.Gly56Gly), rs1368993508, gnomAD 5-170106125-G-T, CADD 10.20
Public FOXI1 analysis runs
- FOXI1 analysis run — FOXI1 (933 variants) — completed 2026-08-22